Figures | p. ix |
Preface | p. xi |
Who's Who in Eye Care | p. xiii |
Test Your Knowledge | p. xiv |
The Eye Examination | p. 1 |
Objectives | p. 1 |
Relevance | p. 1 |
Basic Information | p. 2 |
The Patient's History | p. 2 |
Anatomy | p. 3 |
Anatomic Aging Changes | p. 6 |
Optics | p. 8 |
Visual Acuity | p. 8 |
When To Examine | p. 9 |
Additional Tests | p. 9 |
How to Examine | p. 9 |
Distance Visual Acuity Testing | p. 10 |
Near Visual Acuity Testing | p. 12 |
Visual Acuity Estimation in an Uncooperative Patient | p. 12 |
Confrontation Field Testing | p. 13 |
Amsler Grid Testing | p. 14 |
External Inspection | p. 14 |
Upper Lid Eversion | p. 15 |
Ocular Motility Testing | p. 15 |
Pupillary Reaction Testing | p. 15 |
Anterior Chamber Depth Assessment | p. 16 |
Intraocular Pressure Measurement | p. 17 |
Color Vision Testing | p. 19 |
Fluorescein Staining of Cornea | p. 19 |
Ophthalmoscopy | p. 19 |
Summary of Steps in Eye Examination | p. 24 |
Management or Referral | p. 25 |
Reduced Visual Acuity | p. 25 |
Abnormal Fundus Appearance | p. 25 |
Shallow Anterior Chamber Depth/Elevated Intraocular Pressure | p. 26 |
Points to Remember | p. 26 |
Sample Problems | p. 26 |
Annotated Resources | p. 28 |
Acute Visual Loss | p. 31 |
Objectives | p. 31 |
Relevance | p. 31 |
Basic Information | p. 31 |
How to Examine | p. 32 |
Visual Acuity Testing | p. 32 |
Confrontation Field Testing | p. 32 |
Pupillary Reactions | p. 32 |
Ophthalmoscopy | p. 32 |
Penlight Examination | p. 33 |
Tonometry | p. 33 |
How to Interpret the Findings | p. 33 |
Media Opacities | p. 33 |
Corneal Edema | p. 33 |
Hyphema | p. 33 |
Cataract | p. 34 |
Vitreous Hemorrhage | p. 34 |
Retinal Disease | p. 35 |
Optic Nerve Disease | p. 39 |
Visual Pathway Disorders | p. 42 |
Functional Disorders | p. 43 |
Acute Discovery of Chronic Visual Loss | p. 43 |
Points to Remember | p. 43 |
Sample Problems | p. 44 |
Annotated Resources | p. 46 |
Chronic Visual Loss | p. 49 |
Objectives | p. 49 |
Chronic Visual Loss in the Geriatric Population | p. 49 |
Glaucoma | p. 50 |
Relevance | p. 50 |
Basic Information | p. 52 |
Intraocular Pressure | p. 52 |
Types of Glaucoma | p. 53 |
Optic Nerve | p. 53 |
Relationship of Iop and Optic Nerve | p. 54 |
When to Examine | p. 54 |
How to Examine | p. 54 |
How to Interpret the Findings | p. 55 |
Management or Referral | p. 57 |
Cataract | p. 57 |
Relevance | p. 57 |
Basic Information | p. 58 |
Lens | p. 59 |
Cataract | p. 59 |
Symptoms of Cataract | p. 59 |
When to Examine | p. 60 |
How to Examine | p. 61 |
How to Interpret the Findings | p. 62 |
Management or Referral | p. 62 |
Macular Degeneration | p. 63 |
Relevance | p. 63 |
Basic Information | p. 63 |
Macular Anatomy | p. 63 |
Age-Related Macular Changes | p. 64 |
When to Examine | p. 67 |
How to Examine | p. 67 |
How to Interpret the Findings | p. 68 |
Management or Referral | p. 68 |
The Visually Impaired Patient | p. 69 |
Points to Remember | p. 70 |
Sample Problems | p. 71 |
Annotated Resources | p. 72 |
The Red Eye | p. 75 |
Objectives | p. 75 |
Relevance | p. 75 |
Basic Information | p. 75 |
Disorders Associated with a Red Eye | p. 76 |
History | p. 79 |
How to Examine | p. 80 |
How to Interpret the Findings | p. 82 |
Symptoms of Red Eye | p. 83 |
Signs of Red Eye | p. 85 |
Associated Systemic Problems | p. 87 |
Laboratory Diagnosis | p. 87 |
Management or Referral | p. 88 |
Blepharitis | p. 88 |
Stye and Chalazion | p. 90 |
Subconjunctival Hemorrhage | p. 91 |
Conjunctivitis | p. 91 |
Therapeutic Warnings | p. 92 |
Topical Anesthetics | p. 92 |
Topical Corticosteroids | p. 92 |
Points to Remember | p. 92 |
Sample Problems | p. 93 |
Annotated Resources | p. 97 |
Ocular and Orbital Injuries | p. 99 |
Objectives | p. 99 |
Relevance | p. 99 |
Basic Information | p. 100 |
Anatomy and Function | p. 100 |
When to Examine | p. 103 |
How to Examine | p. 103 |
History | p. 104 |
Visual Acuity Testing | p. 104 |
External Examination | p. 105 |
Pupillary Reactions | p. 107 |
Ocular Motility Testing | p. 107 |
Ophthalmoscopy | p. 107 |
Radiologic Studies | p. 107 |
Management or Referral | p. 108 |
True Emergency | p. 108 |
Urgent Situation | p. 108 |
Semiurgent Condition | p. 110 |
Treatment Skills | p. 111 |
Ocular Irrigation | p. 111 |
Foreign-Body Removal | p. 112 |
Prescribing Eye Medication | p. 112 |
Patching | p. 112 |
Suturing | p. 113 |
Points to Remember | p. 113 |
Sample Problems | p. 114 |
Annotated Resources | p. 118 |
Amblyopia and Strabismus | p. 121 |
Objectives | p. 121 |
Relevance | p. 121 |
Basic Information | p. 122 |
Amblyopia | p. 122 |
Strabismus | p. 124 |
How to Examine and Interpret the Findings | p. 126 |
Amblyopia Testing | p. 127 |
Strabismus Testing | p. 129 |
Other Tests | p. 133 |
Management or Referral | p. 134 |
Amblyopia | p. 134 |
Strabismus | p. 135 |
Points to Remember | p. 136 |
Sample Problems | p. 136 |
Annotated Resources | p. 140 |
Neuro-Ophthalmology | p. 141 |
Objectives | p. 141 |
Relevance | p. 141 |
How to Examine | p. 142 |
Visual Acuity Testing | p. 142 |
Visual Field Testing | p. 142 |
Pupillary Reactions | p. 143 |
Ocular Motility Testing | p. 144 |
Ophthalmoscopy | p. 145 |
How to Interpret the Findings | p. 146 |
Pupillary Disorders | p. 146 |
Other Cranial Nerve Palsies | p. 150 |
Optic Nerve Disease | p. 153 |
Visual Field Defects | p. 156 |
Visual Hallucinations | p. 157 |
Cognitive Visual Loss: The Visual Variant of Alzheimer's Disease | p. 159 |
Points to Remember | p. 159 |
Sample Problems | p. 160 |
Annotated Resources | p. 164 |
Ocular Manifestations of Systemic Disease | p. 165 |
Objectives | p. 165 |
Relevance | p. 165 |
Diabetes Mellitus | p. 166 |
Hypertension | p. 170 |
Arteriolar Sclerosis | p. 170 |
Elevated Blood Pressure | p. 172 |
Diagnostic Concerns | p. 172 |
Management | p. 172 |
Pregnancy | p. 173 |
Sickle Cell Anemia | p. 174 |
Thyroid Disease | p. 174 |
Sarcoidosis and Other Inflammatory and Autoimmune Conditions | p. 175 |
Malignancy | p. 176 |
Acquired Immunodeficiency Syndrome | p. 177 |
Syphilis | p. 179 |
Other Systemic Infections | p. 179 |
Points to Remember | p. 180 |
Sample Problems | p. 181 |
Annotated Resources | p. 182 |
Drugs and the Eye | p. 185 |
Objectives | p. 185 |
Relevance | p. 185 |
Basic Information | p. 187 |
Topical Ocular Diagnostic Drugs | p. 188 |
Fluorescein Dye | p. 188 |
Anesthetics | p. 188 |
Mydriatics | p. 189 |
Topical Ocular Therapeutic Drugs | p. 190 |
Decongestants | p. 190 |
Agents for Relief of Allergic Conjunctivitis | p. 191 |
Anti-Inflammatory Agents | p. 191 |
Agents for the Relief of Dry Eye Symptoms | p. 191 |
Antibiotics | p. 191 |
Antiviral Agents | p. 192 |
Systemic Side Effects of Glaucoma Medications | p. 192 |
Beta-Adrenergic Blockers | p. 192 |
Cholinergic-Stimulating Drugs | p. 193 |
Alpha-2 Adrenoreceptor Agonists | p. 194 |
Adrenergic-Stimulating Drugs | p. 194 |
Prostaglandin Analogues | p. 195 |
Carbonic Anhydrase Inhibitors | p. 195 |
Ocular Side Effects of Systemic Drugs | p. 195 |
Amiodarone | p. 195 |
Biphosphonates | p. 196 |
Chloroquines | p. 196 |
Chlorpromazine | p. 197 |
Corticosteroids | p. 197 |
Digitalis | p. 197 |
Diphenylhydantoin | p. 197 |
Ethambutol | p. 197 |
Hmg-Coa Reductase Inhibitors (Statins) | p. 198 |
Rifabutin (Mycobutin) | p. 198 |
Sildenafil (Viagra) and Tadalifil (Cialis) | p. 198 |
Thioridazine | p. 198 |
Topiramate (Topimax) | p. 198 |
Points to Remember | p. 199 |
Sample Problems | p. 199 |
Annotated Resources | p. 202 |
Index | p. 203 |
Table of Contents provided by Rittenhouse. All Rights Reserved. |